Sun Yi, Gao Lujuan, He Chengyan, Li Ming, Zeng Tongxiang
Department of Dermatology, Jingzhou Central Hospital, The Second Clinical Medical College, Yangtze University, Jingzhou, 434100, China.
Department of Dermatology, Zhongshan Hospital Fudan University, Shanghai, 200032, China.
Med Mycol. 2018 Nov 1;56(8):1045-1049. doi: 10.1093/mmy/myx150.
In vitro interactions of AT406, a novel IAP antagonist, and azoles including itraconazole, voriconazole, and fluconazole against planktonic cells and biofilms of Candida albicans and Exophiala dermatitidis were assessed via broth microdilution checkerboard technique. AT406 alone exhibited limited antifungal activity. However, synergistic effect between AT406 and fluconazole was observed against both planktonic cells and biofilms of C. albicans, including one fluconazole-resistant strain. Moreover, synergism was also demonstrated between AT406 and itraconazole against both planktonic cells and biofilms of E. dermatitidis. No interaction was observed between AT406 and voriconazole. No antagonism was observed in all combinations.
通过肉汤微量稀释棋盘法评估了新型IAP拮抗剂AT406与包括伊曲康唑、伏立康唑和氟康唑在内的唑类药物对白色念珠菌和皮炎外瓶霉的浮游细胞及生物膜的体外相互作用。单独使用AT406时表现出有限的抗真菌活性。然而,观察到AT406与氟康唑对白色念珠菌的浮游细胞和生物膜均有协同作用,包括一株氟康唑耐药菌株。此外,AT406与伊曲康唑对皮炎外瓶霉的浮游细胞和生物膜也表现出协同作用。未观察到AT406与伏立康唑之间有相互作用。在所有组合中均未观察到拮抗作用。